Respiratory Research (Oct 2022)

MiR-493-5p inhibits Th9 cell differentiation in allergic asthma by targeting FOXO1

  • Xingyu Rao,
  • Heting Dong,
  • Weili Zhang,
  • Huiming Sun,
  • Wenjing Gu,
  • Xinxing Zhang,
  • Li Huang,
  • Yongdong Yan,
  • Chuangli Hao,
  • Wei Ji,
  • Canhong Zhu,
  • Zhengrong Chen

DOI
https://doi.org/10.1186/s12931-022-02207-2
Journal volume & issue
Vol. 23, no. 1
pp. 1 – 15

Abstract

Read online

Abstract The role of micro RNAs (miRNAs) in asthma remains unclear. In this study, we examined the role of miRNA in targeting FOXO1 in asthma. Results showed that miR-493-5p was one of the differentially expressed miRNAs in the PBMCs of asthmatic children, and was also associated with Th cell differentiation. The miR-493-5p expression decreased significantly in the OVA-induced asthma mice than the control groups. The miR-493-5p mimic inhibited the expression of the IL-9, IRF4 and FOXO1, while the inhibitor restored these effects. Moreover, the Dual-Luciferase analysis results showed FOXO1 as a novel valid target of miR-493-5p. According to the rescue experiment, miR-493-5p inhibited Th9 cell differentiation by targeting FOXO1. Then the exosomes in association with the pathogenesis of asthma was identified. Various inflammatory cells implicated in asthmatic processes including B and T lymphocytes, DCs, mast cells, and epithelial cells can release exosomes. Our results demonstrated that the DC-derived exosomes can inhibit Th9 cell differentiation through miR-493-5p, thus DC-derived exosomal miR-493-5p/FOXO1/Th9 may serve as a potential therapeutic target in the development of asthma.

Keywords